Snow Medical Research Foundation has awarded IMB researchers $8 million to dramatically advance the use of genomics to prevent chronic disease such as type 2 diabetes, heart disease and Alzheimer’s.
Patient recruitment is underway for a University of Queensland-led clinical trial to test the effectiveness of a diabetes drug to slow the progression of polycystic kidney disease (PKD).